US 11,911,485 B2
Ionizable lipid compounds, lipid nanoparticles comprising same and therapeutic uses thereof
Hyukjin Lee, Seoul (KR); Minjeong Kim, Seoul (KR); Hansaem Jeong, Daejeon (KR); Hyokyoung Kwon, Seoul (KR); Yunmi Seo, Seoul (KR); and Michaela Jeong, Seoul (KR)
Assigned to EnhancedBio Inc., Seoul (KR)
Filed by EnhancedBio Inc., Seoul (KR)
Filed on Aug. 1, 2022, as Appl. No. 17/816,427.
Application 17/816,427 is a continuation of application No. 17/504,785, filed on Oct. 19, 2021, granted, now 11,464,870.
Application 17/504,785 is a continuation of application No. PCT/KR2020/019502, filed on Dec. 31, 2020.
Claims priority of application No. 10-2020-0005642 (KR), filed on Jan. 15, 2020; and application No. 10-2020-0040586 (KR), filed on Apr. 2, 2020.
Prior Publication US 2023/0310644 A1, Oct. 5, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 47/69 (2017.01); A61K 31/7105 (2006.01); A61K 31/711 (2006.01); A61K 47/22 (2006.01); A61K 47/24 (2006.01); A61K 47/28 (2006.01); A61K 48/00 (2006.01)
CPC A61K 47/6909 (2017.08) [A61K 31/7105 (2013.01); A61K 31/711 (2013.01); A61K 47/22 (2013.01); A61K 47/24 (2013.01); A61K 47/28 (2013.01); A61K 48/00 (2013.01)] 19 Claims
OG exemplary drawing
 
1. An ionizable lipid compound represented by the following formula:

OG Complex Work Unit Chemistry